Trial Profile
Study of sofosbuvir and ledipasvir without ribavirin for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 05 Jun 2018 New trial record